Navigation Links
NextDocs and Novella to Present on eTMF at DIA 2013
Date:6/19/2013

CONSHOHOCKEN, Pa., June 19, 2013 /PRNewswire/ -- NextDocs announced today that it will co-present with Novella, a full service clinical research organization, at DIA 2013, the Drug Information Association annual meeting and conference.  The companies will present case studies that explore best practices for making the transition from paper trial master file to electronic trial master file (eTMF) systems.

Sharon Ames, enterprise program director at NextDocs will present alongside Krystyna Kowalczyk, executive vice president of clinical operations at Novella, in a session entitled, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF."  The session will examine how to structure a paper-to-electronic transition that incorporates the needs of ongoing studies while also meeting regulatory needs and reducing operational impacts. 

DIA 2013, the 49th annual meeting and conference of the DIA, is the largest multidisciplinary event for the pharmaceutical and life sciences industry, focusing on advancing therapeutic innovation and regulatory science.  The DIA 2013 conference takes place at the Convention and Exhibition Center in Boston from June 23 - 27, 2013. 

NextDocs and Novella's session, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF," will take place on Monday, June 24, 2013 at 2:30 p.m.  Additionally, NextDocs will be demonstrating its solutions at the DIA conference in booth #1722.

For more information on DIA 2013, visit www.diahome.org.   For more information on NextDocs, visit www.nextdocs.com.

CONTACT:
Dan Cahill
'/>"/>

SOURCE NextDocs
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NextDocs Expands Customer Roster by More Than 10 Percent
2. NextDocs Launches QuickStart for Emerging Growth Companies
3. NextDocs 6: The New Enterprise Standard for Regulated Content Management
4. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
5. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Pharma IQ Presents the Latest Trends in Clinical Trial Supply
8. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
9. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
10. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
11. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... Israel , July 10, 2014   ... Diabetes Management Solution, today announced the appointment of ... independent member of its Board of Directors. ... legal and business experience to LabStyle as an ... and legal and corporate governance expert. He currently ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Dow Jones Sustainability Indexes for Six Consecutive Years... -- ABBOTT PARK, Ill., Sept. 9 ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... Pharmaceuticals, LLC announced today the approval of a new, ... 0.0375%, for the treatment of acne vulgaris. An excellent ... between strength – effective yet gentle. Tretin-X 0.0375% ... those patients already on tretinoin therapy for acne, Tretin-X ...
Cached Medicine Technology:Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 2Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 3Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 4Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 5Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 6Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 7Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 8New, Exclusive Strength: Tretin-X® 0.0375%(tretinoin) Cream 2
(Date:7/11/2014)... Butler Mobility has recently updated the paint ... . Previously the two standard colors were beige and ... tone colors as standard colors at no additional charge! ... but will enhance the beauty of the stairway. Homeowners ... scheme or individual décor. , The new selection of standard ...
(Date:7/11/2014)... London, UK (PRWEB) July 11, 2014 ... segment of the in-vitro diagnostics industry, which is expected ... next ten years. The sector owes its growth to ... threat to people’s health worldwide and a major factor ... diagnostic technologies, threat of bio-terrorism, and a broader availability ...
(Date:7/11/2014)... 2014 Utilizing the Keller Funnel, ... Koenig, has topped a record number of complication-free breast ... over 400 successful procedures without the occurrence of a ... known across the country for his expertise with the ... long been the foundation for numerous studies and research. ...
(Date:7/11/2014)... Oakland, CA (PRWEB) July 11, 2014 Ticket ... tickets at the Concord Pavilion . When it comes to ... from Luke Bryan. The 37-year-old Georgia native is one of the ... in the entertainment business. Bryan is currently out on his “That’s ... Among the many stops the tour will be making through the ...
(Date:7/11/2014)... Biostimulants are widely applied in turf and ... These also help turf and ornamentals in absorption of ... ornamentals, and flowers appear healthy and strong as a ... from the last few years. The most dominating region ... with around 40% share in 2013, and is estimated ...
Breaking Medicine News(10 mins):Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3
... Through exercise, it seems to boost activity in a key ... -- U.S. researchers say they,ve developed a hand-exercising robotic device ... more than six months after a stroke. , Brain ... stroke-afflicted hands, boosted activity in the part of the brain ...
... Sheets: GOHE) announced today that the company has gained over 60 ... Recovery Shakes and Bars, including many of the top names of ... , Stuart Evey, Chairman of Go Healthy and formerly ... products are received by athletes and coaches. Implementation of sales ...
... Mass., Dec. 4 Decision Resources, one of ... pharmaceutical and,healthcare issues, finds that Eisai/Helsinn Healthcare,s Aloxi,s ... rated the most influential,by oncologists in the chemotherapy-induced ... messages with the brand,highlighting the strength of the ...
... Integration with McKesson PACS and Kodak Carestream to ... , , CHICAGO, ... disparate healthcare IT systems, and Medical Imaging Northwest ... Enterprise-wide worklist solution, integrating digital imaging and data ...
... New York Medicaid Managed Care Model Compliance Guidance ... 4 The Health Care Compliance Association (HCCA) announced ... Compliance conference, February 22-24, 2009, in Scottsdale, Arizona. The ... for the industry, is intended to provide essential information ...
... Celebrity duo bring sports flavor to the conversation about a ... CARY, N.C., Dec. 4 College basketball analyst ... Pardon the Interruption Michael Wilbon have teamed up with ESPN, ... Cancer(TM) in an effort to create a national discussion about ...
Cached Medicine News:Health News:Robotic Device Could Help Stroke Patients 2Health News:Robotic Device Could Help Stroke Patients 3Health News:Go Healthy Updates Progress With University Sports Programs 2Health News:Oncologists Rank Aloxi's Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market 2Health News:Medical Imaging Northwest Selects Compressus for Enterprise Interoperability 2Health News:Medical Imaging Northwest Selects Compressus for Enterprise Interoperability 3Health News:Medical Imaging Northwest Selects Compressus for Enterprise Interoperability 4Health News:HCCA Announces Managed Care Compliance Conference, February 22-24, 2009, Scottsdale, Arizona 2Health News:HCCA Announces Managed Care Compliance Conference, February 22-24, 2009, Scottsdale, Arizona 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 2Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: